The Grifols group of companies serves healthcare
professionals and patients in over 90 countries around the world. We research,
develop, manufacture and market plasma derivatives, IV therapy, diagnostic
systems and medical materials.
Bioscience
The Bioscience Division specializes in the development of high quality plasma
derivatives with outstanding records of safety and efficacy. Grifols Bioscience
provides plasma products to patients around the world.
Grifols's extensive plasma derivatives safety program includes a rigorous
methodology, cutting edge technologies, experienced staff and full traceability
from plasma donation to final product. From donor to patient. Click here
to learn more about Our Commitment to
Safety.
Patient Educational Materials:
For more information, please contact us Click here.
Hospital
The hospital division provides simple, cost-effective solutions to operational
challenges in pharmacy.
Its primary focus is on sterile IV preparations for specialty therapies such as
pain management, oncology, and pediatrics.
For the latest update to Grifols Guide to USP <797>
Click here.
For more information, please contact us. Click here.
Diagnostic
The Diagnostics Division focuses on the development of in-vitro diagnostic
products for the laboratory.
Grifols is a world leader in the development and manufacture of blood-typing,
coagulation and EIA Automatic Analyzers. The company specializes in providing
full technical support and field services for any EIA application that
customers choose to validate and automate in the Grifols Triturus ELISA
Analyzer.
Products &
Services
